Iganga Mayuge HDSS and drug regulatory authority in pharmacovigilance study
24 Jan 2017
The Iganga-Mayuge Health and Demographic Surveillance Site (IMHDSS) which is managed by Makerere University Centre for Health and Population Research (MUCHAP) has partnered with the Uganda National Drug Authority (NDA) to implement a community dialogue and sensitization campaign to improve reporting of suspected adverse drug reactions by patients and healthcare workers in Iganga and Mayuge districts community. The campaign was launched in December 2016 in Iganga town attended by district technical and political leadership, health managers and their healthcare teams, religious and cultural leaders, Sub-County leaders, drug shop operators, clinics, pharmacies and nurses in boarding schools from both Iganga and Mayuge.
The role of patients as key contributors in pharmacovigilance (drug safety monitoring) is now fully acknowledged globally (EU pharmacovigilance legislation mandates patient reporting). Where patient reporting is operational (EMEA and Netherlands), it has been identified to facilitate faster signal detection and current methods used in pharmacovigilance need to optimise use of the information reported from patients. This initiative will help provide information on the factors that drive patient reporting in our communities to guide NDA efforts towards improving patient involvement in drug safety monitoring, including the further development of a patient-specific form, development of a severity grading and evolution of the database structure and the signal detection methods. Read more